IMMUNOTHERAPY OF RENAL-CELL CARCINOMA

被引：28

作者：

HAAS, GP

HILLMAN, GG

REDMAN, BG

PONTES, JE

机构：

[1] Section of Urological Oncology, Departmet of Urology at Wayne State University School of Medicie, Detroit, Michigan

[2] Immunology Research Laboratory, Department of Medicine, Detroit, Michigan

[3] Divisio of Hematology/Oncology, Wayne State University School of Medicine, Detroit, Michigan

[4] Department of Urology, Waye state Uiversity School of Medicine, Detrot, Michigan

来源：

CA-A CANCER JOURNAL FOR CLINICIANS | 1993年 / 43卷 / 03期

关键词：

D O I：

10.3322/canjclin.43.3.177

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunologic approaches to the therapy of metastatic renal cell carcinoma have provided moderate improvement in response rates for a disease that is extremely resistant to all forms of treatment. This article reviews recent clinical efforts using immunotherapy for renal cell carcinoma, including the adoptive transfer of cytotoxic killer cells and/or the use of biologic response modifiers, such as interferon and interleukin-2.

引用

页码：177 / 187

页数：11

共 55 条

[1]

Boring CC, Squires TS, Tong T, Cancer Statistics: 1993, CA Cancer J Clin, 43, pp. 7-26, (1993)

[2]

Stenzl A, deKernion JB, Pathology, biology, and clinical staging of renal cell carcinoma, Semin Oncol, 16, pp. 3-11, (1989)

[3]

Bloom HJ, Hormone‐induced and spontaneous regression of metastatic renal cancer, Cancer, 32, pp. 1066-1071, (1973)

[4]

Yagoda A, Chemotherapy of renal cell carcinoma:1983–1989, Semin Urol, 7, pp. 199-206, (1989)

[5]

Montie JE, Stewart BH, Straffon RA, Et al., The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma, J Urol, 117, pp. 272-275, (1977)

[6]

de Riese W, Allhoff E, Kirchner H, Et al., Complete spontaneous regression in metastatic renal cell carcinoma: An update and review, World Journal of Urology, 9, pp. 184-191, (1991)

[7]

Quesada JR, Rios A, Swanson D, Et al., Antitumor activity of recombinant‐derived interferon alpha in metastatic renal cell carcinoma, J Clin Oncol, 3, pp. 1522-1528, (1985)

[8]

Figlin RA, deKernion JB, Mukamel E, Et al., Recombinant interferon alfa‐2a in metastatic renal cell carcinoma: Assessment of antitumor activity and anti‐interferon antibody formation, J Clin Oncol, 6, pp. 1604-1610, (1988)

[9]

Muss HB, Interferon therapy of metastatic renal cell cancer, Seminars in Surgical Oncology, 4, pp. 199-203, (1988)

[10]

Balkwill FR, Moodie EM, Positive interactions between human interferon and cyclophosphamide or Adriamycin in a human tumor model system, Cancer Res, 44, pp. 904-908, (1984)

← 1 2 3 4 5 6 →